WallStSmart
PBM

Psyence Biomedical Ltd. Common Shares

NASDAQ: PBM · HEALTHCARE · BIOTECHNOLOGY

$6.59
+29.72% today

Updated 2026-04-30

Market cap
$16.17M
P/E ratio
P/S ratio
EPS (TTM)
$-389.98
Dividend yield
52W range
$2 – $75
Volume
3.0M

Psyence Biomedical Ltd. Common Shares (PBM) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
1 of 8
Last 8 quarters
Avg EPS surprise
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
+99.8%
Most recent quarter

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-46.6%
Last 1 reports
Positive reaction rate
0%
0 of 1 quarters
Largest single-day move
-46.6%
2025-11-20
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2025-11-20$-0.51$2.79$1.49-46.6%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-09-30$0.00$-0.51
2025-03-31$0.00$-99.97
2024-12-31$0.00$4.06
2024-09-30$25.46
2023-09-30$-314.51
2023-06-30$-29.21
2023-03-31$-8.00
2022-12-31$0.05
2022-09-30$0.03
2022-06-30$0.07
2022-03-31$0.25
2021-12-31$950.13

Frequently asked questions

Has Psyence Biomedical Ltd. Common Shares beaten earnings estimates?
Psyence Biomedical Ltd. Common Shares has beaten Wall Street EPS estimates in 1 of its last 8 quarterly reports.
How does PBM stock react to earnings?
PBM stock has moved an average of -46.6% in the trading day following earnings over its last 1 reports, with positive reactions in 0% of those quarters.